<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about PJP</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 23 May 2013 13:01:02 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=PJP" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/eli-lilly-and-company-lly-exdividend-date-scheduled-for-may-14-2013-cm245463">
      <guid isPermaLink="false">245463</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ytNQ5NxdGjE/eli-lilly-and-company-lly-exdividend-date-scheduled-for-may-14-2013-cm245463</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2013</title>
      <description>Eli Lilly and Company (  LLY  ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on June 10, 2013. Shareholders who purchased LLY&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ytNQ5NxdGjE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 15:39:06 Z</pubDate>
      <a10:updated>2013-05-13T13:20:21Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>LLY</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
      <nasdaq:tickers>XPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/eli-lilly-and-company-lly-exdividend-date-scheduled-for-may-14-2013-cm245463</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485">
      <guid isPermaLink="false">245485</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/reFOOhXCKA0/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013</title>
      <description>Amgen Inc. (  AMGN  ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/reFOOhXCKA0" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 15:39:06 Z</pubDate>
      <a10:updated>2013-05-13T13:21:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/sp-highlights-biotech-etfs-cm245131">
      <guid isPermaLink="false">245131</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RPBc3YBXZ00/sp-highlights-biotech-etfs-cm245131</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>S&amp;P Highlights Biotech ETFs</title>
      <description>Bolstered by an accommodating Food &amp;amp; Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/RPBc3YBXZ00" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 10 May 2013 15:39:21 Z</pubDate>
      <a10:updated>2013-05-10T21:17:39Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/sp-highlights-biotech-etfs-cm245131</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/earnings-trigger-volume-spike-in-pharma-etf-cm242713">
      <guid isPermaLink="false">242713</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QlvJh8kX3oY/earnings-trigger-volume-spike-in-pharma-etf-cm242713</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>Earnings Trigger Volume Spike in Pharma ETF</title>
      <description>On Tuesday, it was Pfizer (NYSE:  PFE  ).  Wednesday, it is Merck (NYSE:  MRK  ). Earnings reports from the two pharmaceuticals giants and Dow components have triggered two consecutive volume&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/QlvJh8kX3oY" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 01 May 2013 22:41:27 Z</pubDate>
      <a10:updated>2013-05-03T15:55:30Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>VHT</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/earnings-trigger-volume-spike-in-pharma-etf-cm242713</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/best-etf-buys-for-sell-in-may-and-go-away-script-cm237934">
      <guid isPermaLink="false">237934</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/14yJPIkJYg0/best-etf-buys-for-sell-in-may-and-go-away-script-cm237934</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Best ETF Buys For "Sell In May And Go Away" Script</title>
      <description>May is a seasonally weak month for the stock market, hence the adage, "Sell in May and go away." We asked several asset managers to share their best ETF investing idea, assuming a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/14yJPIkJYg0" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 18 Apr 2013 01:27:00 Z</pubDate>
      <a10:updated>2013-04-18T00:09:26Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>BKLN</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>SPLV</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
      <nasdaq:tickers>UUP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/best-etf-buys-for-sell-in-may-and-go-away-script-cm237934</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/etf-showdown-a-pharma-fight-cm236110">
      <guid isPermaLink="false">236110</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/11N6u-jrczM/etf-showdown-a-pharma-fight-cm236110</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <category>US Markets</category>
      <title>ETF Showdown: A Pharma Fight</title>
      <description>Much has been made of low volatility sectors leading U.S. equities to new all-time highs. Sectors such as  consumer staples and utilities are driving the broader market higher  .  Health care&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/11N6u-jrczM" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 12 Apr 2013 00:21:34 Z</pubDate>
      <a10:updated>2013-04-15T14:29:43Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/etf-showdown-a-pharma-fight-cm236110</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-april-03-2013-cm232677">
      <guid isPermaLink="false">232677</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t_RLAHVfgE8/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-april-03-2013-cm232677</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 03, 2013</title>
      <description>Bristol-Myers Squibb Company (  BMY  ) will begin trading ex-dividend on April 03, 2013. A cash dividend payment of $0.35 per share is scheduled to be paid on May 01, 2013. Shareholders who&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/t_RLAHVfgE8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 02 Apr 2013 17:00:03 Z</pubDate>
      <a10:updated>2013-04-02T13:17:19Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BMY</nasdaq:tickers>
      <nasdaq:tickers>FDL</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>XPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-april-03-2013-cm232677</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/2-etfs-to-buy-now-cm218233">
      <guid isPermaLink="false">218233</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fT5_RA241E4/2-etfs-to-buy-now-cm218233</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>2 ETFs to Buy Now</title>
      <description>What do you do when the market is so overbought that you can’t bring yourself to buy anything, but not so overbought that you feel comfortable running out and shorting everything?  What I do&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fT5_RA241E4" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 15 Feb 2013 21:32:37 Z</pubDate>
      <a10:updated>2013-02-15T16:32:40Z</a10:updated>
      <author>Teeka Tiwari</author>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/2-etfs-to-buy-now-cm218233</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/eli-lilly-and-company-lly-exdividend-date-scheduled-for-february-13-2013-cm216042">
      <guid isPermaLink="false">216042</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kHhlafGVJ9Y/eli-lilly-and-company-lly-exdividend-date-scheduled-for-february-13-2013-cm216042</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 13, 2013</title>
      <description>Eli Lilly and Company (  LLY  ) will begin trading ex-dividend on February 13, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on March 08, 2013. Shareholders who&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/kHhlafGVJ9Y" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Feb 2013 19:00:04 Z</pubDate>
      <a10:updated>2013-02-11T15:00:56Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>FDL</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>LLY</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>XPH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/eli-lilly-and-company-lly-exdividend-date-scheduled-for-february-13-2013-cm216042</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021">
      <guid isPermaLink="false">215021</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CcNRkw17oVg/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2013</title>
      <description>Amgen Inc. (  AMGN  ) will begin trading ex-dividend on February 11, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on March 07, 2013. Shareholders who purchased AMGN&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/CcNRkw17oVg" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 07 Feb 2013 19:00:04 Z</pubDate>
      <a10:updated>2013-02-07T14:25:44Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>IYH</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-february-11-2013-cm215021</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-january-02-2013-cm202635">
      <guid isPermaLink="false">202635</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fsqSRcRiHac/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-january-02-2013-cm202635</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 02, 2013</title>
      <description>Bristol-Myers Squibb Company (  BMY  ) has announced an ex-dividend date of January 02, 2013 and a cash dividend payment of $0.35 per share scheduled for February 01, 2013. Shareholders who&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fsqSRcRiHac" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 28 Dec 2012 19:00:03 Z</pubDate>
      <a10:updated>2012-12-28T14:20:45Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BMY</nasdaq:tickers>
      <nasdaq:tickers>GVT</nasdaq:tickers>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bristolmyers-squibb-company-bmy-exdividend-date-scheduled-for-january-02-2013-cm202635</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/spectrum-pharmaceuticals-inc-sppi-exdividend-date-scheduled-for-december-18-2012-cm199095">
      <guid isPermaLink="false">199095</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7_0XMV7669w/spectrum-pharmaceuticals-inc-sppi-exdividend-date-scheduled-for-december-18-2012-cm199095</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Spectrum Pharmaceuticals, Inc. (SPPI) Ex-Dividend Date Scheduled for December 18, 2012</title>
      <description>Spectrum Pharmaceuticals, Inc. (  SPPI  ) has announced an ex-dividend date of December 18, 2012 and a cash dividend payment of $0.15 per share scheduled for December 28, 2012. Shareholders who&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7_0XMV7669w" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 14 Dec 2012 19:00:03 Z</pubDate>
      <a10:updated>2012-12-14T14:28:59Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>EWSM</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>SPPI</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/spectrum-pharmaceuticals-inc-sppi-exdividend-date-scheduled-for-december-18-2012-cm199095</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/sp-likes-a-trio-of-biotech-etfs-cm184272">
      <guid isPermaLink="false">184272</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9WFPfT0-Zro/sp-likes-a-trio-of-biotech-etfs-cm184272</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <category>US Markets</category>
      <title>S&amp;P Likes a Trio of Biotech ETFs</title>
      <description>Due to increased FDA approvals and takeover speculation, biotechnology ETFs have already been among the best-performing sector funds this year, but more upside could materialize over the next&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/9WFPfT0-Zro" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 25 Oct 2012 00:09:48 Z</pubDate>
      <a10:updated>2012-10-24T20:39:27Z</a10:updated>
      <author>Benzinga</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/sp-likes-a-trio-of-biotech-etfs-cm184272</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/what-patent-cliff-pharma-etfs-continue-to-surge-etf-news-and-commentary-cm154633">
      <guid isPermaLink="false">154633</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L8RoVJHOLDM/what-patent-cliff-pharma-etfs-continue-to-surge-etf-news-and-commentary-cm154633</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>What Patent Cliff? Pharma ETFs Continue to Surge - ETF News And Commentary</title>
      <description>For at least the past few years, investors in the health care segment have been focused in on big pharma and the segment's fast approaching 'patent cliff'. During this period, many of the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/L8RoVJHOLDM" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 10 Jul 2012 21:47:31 Z</pubDate>
      <a10:updated>2012-07-10T18:48:41Z</a10:updated>
      <author>Eric Dutram</author>
      <nasdaq:tickers>IHE</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>MRK</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/what-patent-cliff-pharma-etfs-continue-to-surge-etf-news-and-commentary-cm154633</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/the-five-best-etfs-over-the-past-five-years-etf-news-and-commentary-cm152677">
      <guid isPermaLink="false">152677</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q0RRp8Vux8Y/the-five-best-etfs-over-the-past-five-years-etf-news-and-commentary-cm152677</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>The Five Best ETFs over the Past Five Years - ETF News And Commentary</title>
      <description>In the last five years, investors have witnessed a variety of market conditions. Stocks were relatively strong in the middle part of 2007 but, as we all know, proceeded to fall apart during the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Q0RRp8Vux8Y" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 02 Jul 2012 20:12:30 Z</pubDate>
      <a10:updated>2012-07-02T17:13:44Z</a10:updated>
      <author>Eric Dutram</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>IAU</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>SLV</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/the-five-best-etfs-over-the-past-five-years-etf-news-and-commentary-cm152677</feedburner:origLink></item>
  </channel>
</rss>
